GRA17

GRA17 is a Toxoplasma gondii dense granule protein that localizes to the parasitophorous vacuole membrane (PVM), where it forms a large non-selective pore mediating passive transport of small molecules across the PVM (PMID:25974303). This pore activity is functionally conserved with the Plasmodium EXP2 translocon, which fully complements GRA17-deficient parasites for PVM permeability, PV morphology, and growth (PMID:25974303). GRA17 operates within a redundant family of pore-forming GRA proteins, acting synergistically with GRA23 and partially interchangeably with GRA47 and GRA72, whose overexpression partially rescues aberrant PV morphology in reciprocal deletion mutants (PMID:25974303, PMID:38380952). Functionally, the GRA17 pore serves as an entry route for host-derived nutrients including glucose, pantothenate, and monocarboxylates such as lactate and pyruvate into the vacuole (PMID:40576341, PMID:42124602). Proper delivery of GRA17 to the PVM depends on the intravacuolar network scaffold GRA1 and on the apical annuli protein AAP7, both of which act upstream of GRA17 secretion (PMID:40576341, PMID:41256620). Loss of GRA17 produces enlarged 'bubble' vacuoles with reduced PVM permeability, structural instability, slow proliferation, avirulence in mice, and impaired chronic infection—including reduced bradyzoite viability within cysts and blocked cyst formation (PMID:25974303, PMID:31572690, PMID:32686022).

1. 2015 High

   Established that GRA17 is the molecular basis of passive small-molecule permeability across the PVM, answering how the intracellular parasite exchanges solutes with the host cytosol.

   Evidence Genetic knockout with PVM permeability assays, Xenopus oocyte electrophysiology, and cross-species complementation with Plasmodium EXP2 in RH strain

   PMID:25974303

   Open questions at the time

   • Pore selectivity and structural architecture not resolved
   • Full spectrum of transported solutes not defined
   • Mechanism of synergy with GRA23 not characterized
2. 2015 High

   Demonstrated that GRA17 pore function is evolutionarily conserved across PV-residing Apicomplexa by showing Plasmodium EXP2 fully rescues GRA17 loss, unifying these pore-forming proteins mechanistically.

   Evidence Heterologous complementation of Toxoplasma GRA17 knockout with Plasmodium EXP2 and functional readouts in RH strain

   PMID:25974303

   Open questions at the time

   • Structural equivalence of the two pores not established
   • Whether native cofactors differ between species unknown
3. 2019 High

   Extended GRA17's role beyond acute infection by showing it is required for bradyzoite viability within cysts, linking PVM permeability to persistence of the chronic stage.

   Evidence CRISPR-Cas9 knockout in ME49 strain with cyst formation and bradyzoite viability assays and stage-specific promoter complementation

   PMID:31572690

   Open questions at the time

   • Specific metabolic requirement of bradyzoites met by GRA17 not identified
   • Whether cyst wall permeability compensates in vivo unknown
4. 2020 Medium

   Confirmed GRA17's requirement for establishing chronic infection by showing deletion abrogates acute infection and blocks cyst formation in a type II strain.

   Evidence CRISPR-Cas9 knockout with mouse infection model and PV morphology analysis in Pru strain

   PMID:32686022

   Open questions at the time

   • Molecular cause of block in cyst formation not defined
   • Contribution of host immune context not dissected
5. 2024 High

   Defined a redundant family of pore-forming GRA proteins by showing GRA47/GRA72 regulate PVM permeability alongside GRA17 and that cross-family and cross-species overexpression rescues morphological defects, clarifying functional interchangeability.

   Evidence Co-immunoprecipitation, multiple CRISPR knockouts, overexpression and PfExp2 complementation, and Xenopus oocyte electrophysiology in RH strain

   PMID:38380952 PMID:38936501

   Open questions at the time

   • Whether these proteins form a shared complex or independent pores unresolved
   • Stoichiometry and assembly of the family not determined
6. 2025 Medium

   Placed GRA1 upstream of GRA17 by showing that GRA1 loss mislocalizes GRA17 and impairs nutrient (glucose, pantothenate) uptake, connecting IVN scaffolding to pore delivery.

   Evidence Conditional depletion of GRA1 with GRA17 localization, nutrient uptake and metabolic assays in RH strain

   PMID:40576341

   Open questions at the time

   • Whether GRA1 directly traffics GRA17 or acts indirectly via IVN not distinguished
   • GRA17 localization was a secondary finding in a GRA1-focused study
7. 2025 Medium

   Identified AAP7 as a secretion factor for GRA17 by showing AAP7 depletion reduces GRA17 secretion and produces bubble vacuoles that GRA17 overexpression reverses, pinpointing GRA17 delivery as the critical downstream defect.

   Evidence Conditional depletion with GRA17 overexpression rescue and PV morphology microscopy in RH strain (preprint)

   PMID:41256620

   Open questions at the time

   • Preprint, single lab
   • Mechanism by which apical annuli protein controls dense granule secretion unknown
8. 2026 Medium

   Assigned monocarboxylates (lactate, pyruvate) as substrates transported by the GRA17 pore by showing GRA17 ablation removes the growth advantage of exogenous lactate, refining the nutrient-uptake role.

   Evidence GRA17 knockout combined with hexokinase knockout and growth assays under elevated exogenous lactate (preprint)

   PMID:42124602

   Open questions at the time

   • Preprint, single lab
   • Direct transport measurement of monocarboxylates through GRA17 not shown

• The structural architecture of the GRA17 pore, its selectivity determinants, and whether the GRA17/GRA23/GRA47/GRA72 family assembles into a shared translocon complex remain unresolved.
• No structural model of the pore
• Assembly and stoichiometry of the pore-forming GRA family undefined
• Direct biochemical demonstration of individual solute transport lacking